Octapharma announces the presentation of the final results from the NuProtect study of Nuwiq (simoctocog alfa) in previously untreated patients (PUPs) at ASH 2019
LACHEN, Switzerland--(BUSINESS WIRE)--Dec 2, 2019--
LACHEN, Switzerland--(BUSINESS WIRE)--Dec 2, 2019--